Suppression of cancer stem-like cell radioresistance by inhibiting AMPK signaling
Journal of Radiation Research · 2025
DOI: 10.1093/jrr/rraf015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, 2025. Verfasst von Tsutomu Shimura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health, National Institute of Public Health, 2-3-6 Minami, Wako 351-0197, Japan. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Radiation Tolerance, Signal Transduction, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cancer stem cell (CSC) radioresistance is a major cause of radiotherapy (RT) failure and tumor recurrence. The molecular target for eradicating CSCs has not been identified despite research efforts to overcome tumor radioresistance. The adenosine monophosphate-activated protein kinase (AMPK) is responsible for transmitting nuclear DNA damage signals to the mitochondria, which in turn generate adenosine triphosphate to execute a DNA damage response. Disruption of this mitochondria-mediated genomic defense mechanism may be an effective strategy to enhance the cytotoxic efficacy of RT. Here, we investigated the potential efficacy of the pan-AMPK inhibitor dorsomorphin (Dor) in preventing CSC radioresistance. Radioresistant cancer stem-like cells were derived from the human liver cancer cell line HepG2 (HepG2 82FR-31NR). The radiosensitizing effect of Dor was then examined in HepG2 82FR-31NR cell cultures by clonogenic assays. Low-dose Dor markedly suppressed the recovery of HepG2 cancer stem-like cells after radiation but had little effect on normal fibroblast proliferation and survival, whether applied alone or in combination with radiation. In conclusion, this study strongly suggests that Dor treatment can radiosensitize cancer stem-like cells at doses that have no significant cytotoxic effects on normal human fibroblasts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental Health, National Institute of Public Health, 2-3-6 Minami, Wako 351-0197, Japan.
- Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose 204-8588, Japan.
- Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, 1-2-3 Kasumi, Hiroshima 734-8553 , Japan.
Zitieren
APA
Shimura, T., Nara, H., Yamazaki, M., Sasatani, M., & Ushiyama, A. (2025). Suppression of cancer stem-like cell radioresistance by inhibiting AMPK signaling. Journal of Radiation Research. https://doi.org/10.1093/jrr/rraf015
Vancouver
Shimura T, Nara H, Yamazaki M, Sasatani M, Ushiyama A. Suppression of cancer stem-like cell radioresistance by inhibiting AMPK signaling. Journal of Radiation Research. 2025. doi:10.1093/jrr/rraf015
BibTeX
@article{Shimura2025,
author = {Shimura, Tsutomu and Nara, Honoka and Yamazaki, Mayu and Sasatani, Megumi and Ushiyama, Akira},
title = {Suppression of cancer stem-like cell radioresistance by inhibiting AMPK signaling},
journal = {Journal of Radiation Research},
year = {2025},
doi = {10.1093/jrr/rraf015}
}
EUVIMED